annual EBITDA:
-$156.54M-$43.92M(-38.99%)Summary
- As of today (July 6, 2025), EWTX annual EBITDA is -$156.54 million, with the most recent change of -$43.92 million (-38.99%) on December 31, 2024.
- During the last 3 years, EWTX annual EBITDA has fallen by -$113.60 million (-264.53%).
- EWTX annual EBITDA is now -1497.20% below its all-time high of -$9.80 million, reached on December 31, 2019.
Performance
EWTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$45.41M-$494.00K(-1.10%)Summary
- As of today (July 6, 2025), EWTX quarterly EBITDA is -$45.41 million, with the most recent change of -$494.00 thousand (-1.10%) on March 31, 2025.
- Over the past year, EWTX quarterly EBITDA has dropped by -$11.18 million (-32.65%).
- EWTX quarterly EBITDA is now -1315.37% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$167.72M-$11.18M(-7.14%)Summary
- As of today (July 6, 2025), EWTX TTM EBITDA is -$167.72 million, with the most recent change of -$11.18 million (-7.14%) on March 31, 2025.
- Over the past year, EWTX TTM EBITDA has dropped by -$46.33 million (-38.17%).
- EWTX TTM EBITDA is now -5128.15% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EWTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.0% | -32.6% | -38.2% |
| 3 y3 years | -264.5% | -208.9% | -229.7% |
| 5 y5 years | -1497.2% | -1315.4% | -2255.6% |
EWTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -264.5% | at low | -177.9% | at low | -195.3% | at low |
| 5 y | 5-year | -1497.2% | at low | -1163.7% | at low | -2255.6% | at low |
| alltime | all time | -1497.2% | at low | -1315.4% | at low | -5128.1% | at low |
EWTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$45.41M(+1.1%) | -$167.72M(+7.1%) |
| Dec 2024 | -$156.54M(+39.0%) | -$44.91M(+12.8%) | -$156.54M(+8.0%) |
| Sep 2024 | - | -$39.83M(+6.0%) | -$144.96M(+8.1%) |
| Jun 2024 | - | -$37.57M(+9.8%) | -$134.09M(+10.5%) |
| Mar 2024 | - | -$34.23M(+2.7%) | -$121.39M(+7.8%) |
| Dec 2023 | -$112.63M(+58.4%) | -$33.33M(+15.1%) | -$112.63M(+11.2%) |
| Sep 2023 | - | -$28.95M(+16.4%) | -$101.28M(+12.0%) |
| Jun 2023 | - | -$24.88M(-2.3%) | -$90.42M(+10.4%) |
| Mar 2023 | - | -$25.46M(+15.8%) | -$81.88M(+15.1%) |
| Dec 2022 | -$71.12M | -$21.99M(+21.5%) | -$71.12M(+14.9%) |
| Sep 2022 | - | -$18.10M(+10.8%) | -$61.88M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$16.34M(+11.1%) | -$56.79M(+11.7%) |
| Mar 2022 | - | -$14.70M(+15.3%) | -$50.86M(+18.4%) |
| Dec 2021 | -$42.94M(+152.5%) | -$12.74M(-2.1%) | -$42.94M(+17.7%) |
| Sep 2021 | - | -$13.01M(+25.0%) | -$36.49M(+34.8%) |
| Jun 2021 | - | -$10.41M(+53.6%) | -$27.07M(+31.6%) |
| Mar 2021 | - | -$6.78M(+7.7%) | -$20.58M(+21.0%) |
| Dec 2020 | -$17.01M(+73.5%) | -$6.29M(+75.2%) | -$17.01M(+58.8%) |
| Sep 2020 | - | -$3.59M(-8.2%) | -$10.71M(+50.5%) |
| Jun 2020 | - | -$3.91M(+21.9%) | -$7.12M(+121.9%) |
| Mar 2020 | - | -$3.21M | -$3.21M |
| Dec 2019 | -$9.80M | - | - |
FAQ
- What is Edgewise Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual EBITDA year-on-year change?
- What is Edgewise Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly EBITDA year-on-year change?
- What is Edgewise Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM EBITDA year-on-year change?
What is Edgewise Therapeutics annual EBITDA?
The current annual EBITDA of EWTX is -$156.54M
What is the all time high annual EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual EBITDA is -$9.80M
What is Edgewise Therapeutics annual EBITDA year-on-year change?
Over the past year, EWTX annual EBITDA has changed by -$43.92M (-38.99%)
What is Edgewise Therapeutics quarterly EBITDA?
The current quarterly EBITDA of EWTX is -$45.41M
What is the all time high quarterly EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly EBITDA is -$3.21M
What is Edgewise Therapeutics quarterly EBITDA year-on-year change?
Over the past year, EWTX quarterly EBITDA has changed by -$11.18M (-32.65%)
What is Edgewise Therapeutics TTM EBITDA?
The current TTM EBITDA of EWTX is -$167.72M
What is the all time high TTM EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM EBITDA is -$3.21M
What is Edgewise Therapeutics TTM EBITDA year-on-year change?
Over the past year, EWTX TTM EBITDA has changed by -$46.33M (-38.17%)